The addition of these temperature-controlled hybrid containers will provide the cargo carrier’s customers the choice of a wide range of containers in which to transport their pharmaceuticals across its extensive global network.
Qatar Airways’ Chief Officer Cargo, Guillaume Halleux, said: “The logistics around pharmaceutical transportation is complex and being at the forefront of time and temperature sensitive transportation, we understand the intricacies of a seamless cool chain. Through this agreement with SkyCell, we are glad to expand our container offering under QR Pharma and present customers, with more options to transport their sensitive products. The hybrid container establishes an entirely new product offering for our clients that is both safe and sustainable for our businesses and the planet.”
Chiara Venuti, Director Business Development and Airline Partnerships at SkyCell said: “Qatar Airways Cargo is a leading air cargo carrier with a specialised pharmaceutical offering and an extensive network. The co-operation will meet the growing demand for hybrid containers as safe and sustainable pharma solutions for sensitive and critical drugs such as vaccines.”